COVID-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios

Antoine Danchin, Oriane Pagani-Azizi, Gabriel Turinici, Ghozlane Yahiaoui
doi: https://doi.org/10.1101/2020.10.21.20216713

Article Information

doi 
https://doi.org/10.1101/2020.10.21.20216713
History 
  • January 11, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Antoine Danchin*,†,
  2. Oriane Pagani-Azizi‡,
  3. Gabriel Turinici§,# and
  4. Ghozlane Yahiaoui
  1. †Institut Cochin, Paris, France
  2. ‡CEREMADE - ESPCI Paris PSL, Paris, France
  3. §Université Paris Dauphine - PSL Research University, Paris, France
  4. Mathematical Institute, University of Oxford, Oxford, United Kingdom
  1. ↵# Corresponding author; email: gabriel.turinici{at}dauphine.fr
Back to top
Posted January 11, 2022.
Download PDF
Data/Code
Email
COVID-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios
Antoine Danchin, Oriane Pagani-Azizi, Gabriel Turinici, Ghozlane Yahiaoui
medRxiv 2020.10.21.20216713; doi: https://doi.org/10.1101/2020.10.21.20216713
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area